2025 Annual Meeting | C44 - Comprehensive Migraine Update: Advances in Acute, Preventive, and Cognitive Behavioral Therapies

Date Sunday 04/06/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | 29B

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Melissa L. Rayhill, MD, FAAN

Topic(s) Headache

Learning Objectives Participants should be able to discuss pearls to taking a good headache history, list contraindications to migraine acute therapies, discuss key considerations to new migraine therapies, and describe non-pharmacologic options for migraine.

This program is supported in part by an educational grant from Pfizer

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 08:30 AM PDT	Speaker	Comprehensive Migraine Update: Advances in Acute, Preventive, and Cognitive Behavioral Therapies Melissa L. Rayhill, MD, FAAN, Deena Kuruvilla, MD, Rebecca C. Burch, MD
08:30 AM - 09:00 AM PDT	Q&A	Questions and Answers Melissa L. Rayhill, MD, FAAN, Deena Kuruvilla, MD, Rebecca C. Burch, MD

Faculty Disclosures
Melissa L. Rayhill, MD, FAAN	Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with ��ɫ��.
Deena Kuruvilla, MD	Dr. Kuruvilla has received personal compensation for serving as an employee of Cefaly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Kuruvilla has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amgen. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan/abbvie. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Healthline . Dr. Kuruvilla has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Abbvie/Allergan. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ESTES, INGRAM, FOELS & GIBBS, P.A.
Rebecca C. Burch, MD	An immediate family member of Dr. Burch has received personal compensation for serving as an employee of Wellsky. Dr. Burch has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. An immediate family member of Dr. Burch has stock in Wellsky. Dr. Burch has received publishing royalties from a publication relating to health care.

��ɫ����

��ɫ����

��ɫ��

��ɫ��